期刊
ADVANCES IN NEONATAL CARE
卷 19, 期 3, 页码 188-197出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/ANC.0000000000000605
关键词
Bifidobacterium infantis; necrotizing enterocolitis; preterm infants; probiotics; very low birth-weight infants
类别
Background: Probiotic use in the neonatal intensive care unit (NICU) has been linked to reduced rates of necrotizing enterocolitis in preterm infants. Currently, in the United States, probiotic use within the NICU is limited despite being commonly used in other countries. Purpose: To provide an overview of the current practices of using probiotics in preterm infants for the prevention of NEC in the NICU in preselected countries. Methods: A comprehensive literature search was conducted on PubMed and . Also, studies from 2 recent meta-analyses on the topic were reviewed for inclusion. Selection criteria were as follows: studies involving preterm infants using probiotics in the NICU, reporting on the impact of probiotic use on the incidence of necrotizing enterocolitis, published within the last 10 years and in the English language, and originating from the United States, Canada, or any European country. Results: Twenty-three studies were selected. The most common types of probiotics used were Bifidobacterium infantis and Lactobacillus rhamnosus. The most common frequency of administration was daily or twice day. Duration ranged from 10 days to the entire NICU stay. The dosage was commonly 1 billion colony-forming units daily but ranged from 12 million daily to 12 billion per kilogram daily.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据